USA |NASDAQ |USD
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| Oct 27, 2021 | Sep 2021 | $-0.25 | $-0.10 | $0.30 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| Oct 27, 2021 | Sep 2021 | $2.58M | $2.21M | $2.90M |
Ekso Bionics's next earnings date is Wednesday, Oct 27, 2021 for the fiscal quarter ending Sep 2021.
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 1 | $-0.25 | $-0.25 | $-0.25 |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 1 | $-1.05 | $-1.05 | $-1.05 |
| Dec 2022 | 1 | $-1.06 | $-1.06 | $-1.06 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 0 / 0 | $-0.25 | $-0.25 | $-0.26 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 0 / 0 | $-1.05 | $-1.05 | $-1.02 |
| Dec 2022 | 0 / 0 | $-1.06 | $-1.06 | $-1.09 |
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|---|---|---|---|
| Dec 2021 | 1 | $2.76M | $2.76M | $2.76M |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 1 | $9.46M | $9.46M | $9.46M |
| Dec 2022 | 1 | $14.17M | $14.17M | $14.17M |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Oct 27, 2021 | Sep 2021 | $-0.25 | - | - |
| Jul 29, 2021 | Jun 2021 | $-0.25 | $-0.10 | 60.00% |
| Apr 29, 2021 | Mar 2021 | $-0.24 | $-0.34 | -41.67% |
| Feb 25, 2021 | Dec 2020 | $-0.30 | $-0.48 | -60.00% |
| Oct 29, 2020 | Sep 2020 | $-0.39 | $0.30 | 176.92% |
| Jul 30, 2020 | Jun 2020 | $-0.56 | $-1.88 | -238.74% |
| Apr 30, 2020 | Mar 2020 | $-0.61 | $-0.44 | 27.87% |
| Feb 27, 2020 | Dec 2019 | $-0.65 | $-0.60 | 7.69% |
| Oct 30, 2019 | Sep 2019 | $-1.05 | $0.04 | 103.86% |
| Aug 1, 2019 | Jun 2019 | $-1.20 | $-0.60 | 50.00% |
| May 1, 2019 | Mar 2019 | $-1.20 | $-1.50 | -25.00% |
| Feb 28, 2019 | Dec 2018 | $-1.20 | $-1.05 | 12.50% |
| Nov 7, 2018 | Sep 2018 | $-1.35 | $-1.65 | -22.22% |
| Aug 7, 2018 | Jun 2018 | $-1.65 | $-1.95 | -18.18% |
| May 7, 2018 | Mar 2018 | $-1.65 | $-1.95 | -18.18% |
| Mar 13, 2018 | Dec 2017 | $-1.50 | $-2.25 | -50.00% |
| Nov 8, 2017 | Sep 2017 | $-1.95 | $-2.70 | -38.46% |
| Aug 7, 2017 | Jun 2017 | $-4.50 | $-4.78 | -6.27% |
| May 9, 2017 | Mar 2017 | $-6.00 | $-5.70 | 5.00% |
| Mar 7, 2017 | Dec 2016 | $-6.00 | $-4.35 | 27.50% |
| Nov 9, 2016 | Sep 2016 | $-5.15 | $-9.00 | -74.76% |
| Jul 28, 2016 | Jun 2016 | $-4.58 | $-9.15 | -100.00% |
| May 10, 2016 | Mar 2016 | $-4.55 | $-6.60 | -45.05% |
| Mar 14, 2016 | Dec 2015 | $-5.25 | $-9.45 | -80.00% |
| Nov 5, 2015 | Sep 2015 | $-0.30 | $-0.35 | -16.67% |
| Aug 11, 2015 | Jun 2015 | $-0.24 | $-0.42 | -75.00% |
| May 7, 2015 | Mar 2015 | $-0.28 | $-0.28 | - |
| Mar 17, 2015 | Dec 2014 | $-0.21 | $-0.42 | -100.00% |
| Nov 10, 2014 | Sep 2014 | - | $-4.72 | - |
| Aug 8, 2014 | Jun 2014 | - | $-4.80 | - |
| Mar 31, 2014 | Mar 2014 | - | $-128.00 | - |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Feb 25, 2021 | Dec 2020 | $-1.74 | $-2.50 | - |
| Feb 27, 2020 | Dec 2019 | $-0.20 | $-2.66 | - |
| Feb 28, 2019 | Dec 2018 | $-0.45 | $-6.60 | - |
| Mar 13, 2018 | Dec 2017 | $-0.81 | $-15.43 | - |
| Mar 7, 2017 | Dec 2016 | - | $-29.10 | - |
| Mar 14, 2016 | Dec 2015 | - | $-10.50 | - |
| Mar 17, 2015 | Dec 2014 | - | $-137.94 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Oct 27, 2021 | Sep 2021 | $2.58M | - | - |
| Jul 29, 2021 | Jun 2021 | $2.10M | $2.21M | 1.05% |
| Apr 29, 2021 | Mar 2021 | $3.00M | $1.91M | 0.64% |
| Feb 25, 2021 | Dec 2020 | $2.25M | $2.25M | 1.00% |
| Oct 29, 2020 | Sep 2020 | $2.90M | $2.90M | 1.00% |
| Jul 30, 2020 | Jun 2020 | $1.62M | $2.26M | 1.40% |
| Apr 30, 2020 | Mar 2020 | $1.41M | $1.47M | 1.04% |
| Feb 27, 2020 | Dec 2019 | $3.65M | $3.72M | 1.02% |
| Oct 30, 2019 | Sep 2019 | $3.15M | $3.32M | 1.05% |
| Aug 1, 2019 | Jun 2019 | $3.26M | $3.26M | 1.00% |
| May 1, 2019 | Mar 2019 | $3.90M | $3.62M | 0.93% |
| Feb 28, 2019 | Dec 2018 | $3.86M | $3.30M | 0.85% |
| Nov 7, 2018 | Sep 2018 | $2.86M | $2.55M | 0.89% |
| Aug 7, 2018 | Jun 2018 | $3.03M | $2.97M | 0.98% |
| May 7, 2018 | Mar 2018 | $2.98M | $2.52M | 0.84% |
| Mar 13, 2018 | Dec 2017 | $3.00M | $2.45M | 0.82% |
| Nov 8, 2017 | Sep 2017 | - | $1.60M | - |
| Aug 7, 2017 | Jun 2017 | - | $1.87M | - |
| May 9, 2017 | Mar 2017 | - | $1.44M | - |
| Mar 7, 2017 | Dec 2016 | - | $2.59M | - |
| Nov 9, 2016 | Sep 2016 | - | $1.60M | - |
| Jul 28, 2016 | Jun 2016 | - | $1.55M | - |
| May 10, 2016 | Mar 2016 | - | $8.49M | - |
| Mar 14, 2016 | Dec 2015 | - | $1.94M | - |
| Nov 5, 2015 | Sep 2015 | - | $2.92M | - |
| Aug 11, 2015 | Jun 2015 | - | $2.11M | - |
| May 7, 2015 | Mar 2015 | - | $1.69M | - |
| Mar 17, 2015 | Dec 2014 | - | $1.48M | - |
| Nov 10, 2014 | Sep 2014 | - | $1.59M | - |
| Aug 8, 2014 | Jun 2014 | - | $1.20M | - |
| Mar 31, 2014 | Mar 2014 | - | $1.06M | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Feb 25, 2021 | Dec 2020 | $8.88M | $8.88M | 0.00% |
| Feb 27, 2020 | Dec 2019 | $13.87M | $13.92M | 0.34% |
| Feb 28, 2019 | Dec 2018 | $11.90M | $11.33M | -4.77% |
| Mar 13, 2018 | Dec 2017 | $8.00M | $7.35M | -8.09% |
| Mar 7, 2017 | Dec 2016 | - | $14.22M | - |
| Mar 14, 2016 | Dec 2015 | - | $8.66M | - |
| Mar 17, 2015 | Dec 2014 | - | $5.33M | - |
EKSO's next earnings date is Wednesday, Oct 27, 2021 for the fiscal quarter ending Sep 30, 2021.
According to 1 analysts, the average EPS estimation for Ekso Bionics's next quarterly earnings is $-0.25, with a low EPS estimation of $-0.25, and a high estimation of $-0.25.
Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.25, the last 2 month trend is $-0.25, and the 3 month trend is $-0.26.
Based on 1 analysts, the average revenue estimation is $2.58M, with a low revenue estimation of $2.58M, and a high estimation of $2.58M.
Ekso Bionics's previous earnings date was Jul 29, 2021 for its fiscal quarter ended Jun 30, 2021.
EKSO's earnings per share (EPS) was $-0.10, beating the consensus analysts forecast of $-0.25 by 60.00%.
The EPS was higher than the previous fiscal quarter (Mar 2021) by -70.59%, and higher than the same period a year before (Jun 2020) by -94.68%.
Revenues were $2.21M, better than the forecast of $2.10M by 5.29%, up by 15.76% from the previous quarter , and down by -2.34% from the same period last year.
The company reported a net income of $-1.27M.Free cash flow for the quarter was $-3.61M , compared to $-2.00M last quarter and $-4.02M a year before.
EKSO ended the quarter with $2.50M in total debt, a decrease of -32.70% compared to the previous quarter, and a decrease of -18.59% compared to the same quarter a year before.
Ekso Bionics's previous annual earnings date was Feb 25, 2021 for its fiscal year ended Dec 31, 2020.
EKSO's earnings per share (EPS) was $-2.50, missing the consensus analysts forecast of $-1.74 by 43.68% , and higher than the previous year's EPS (Dec 2019) by -6.00%.
Revenues were $8.88M, better than the forecast of $8.88M by 0.00%, and down by -36.18% from previous year's revenue.
The company reported a net income of $-15.82M.
Ekso Bionics reported a free cash flow of $-8.76M for its fiscal year, compared to $-15.83M a year ago.
The company ended the fiscal year with $3.62M in total debt, an increase of 13.97% compared to the previous year.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.